![John Butler](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Butler
Vorstandsvorsitzender bei
AKEBIA THERAPEUTICS, INC.
Vermögen: 2 Mio $ am 31.05.2026
Profil
John P.
Butler is President, Chief Executive Officer & Director at Akebia Therapeutics, Inc. since 2024.
He is Director at Wavebreak Therapeutics Ltd. since 2023.
He is a Member of the Health Section Governing Board at Biotechnology Innovation Organization since 2024.
Former roles include Chief Executive Officer at Inspiration Biopharmaceuticals, Inc. in 2011; Chairman at Keryx Biopharmaceuticals, Inc. from 2016 to 2017; Chairman at American Kidney Fund, Inc. from 2013 to 2015; Chairman at Kidney Care Partners from 2020 to 2024; Independent Director at Harmony Biosciences Management, Inc. from 2018 to 2023; Independent Director at Relypsa, Inc. from 2013 to 2016; Product Manager at Amgen, Inc. from 1995 to 1997; SVP & President-Cardiometabolic & Renal at Genzyme Corp.
from 2009 to 2011; and Head of Sales & Marketing at Hoffmann-La Roche, Inc. Education includes undergraduate studies at Manhattan University and an MBA from Baruch College.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.03.2026 | 2’206’149 ( 0.82% ) | 2 Mio $ | 31.05.2026 |
Aktive Positionen von John Butler
| Unternehmen | Position | Beginn |
|---|---|---|
| AKEBIA THERAPEUTICS, INC. | Vorstandsvorsitzender | 16.09.2013 |
Wavebreak Therapeutics Ltd.
 Wavebreak Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops small molecule therapeutics for multiple protein misfolding diseases | Direktor/Vorstandsmitglied | 01.01.2023 |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Corporate Officer/Principal | 01.01.2024 |
Ehemalige bekannte Positionen von John Butler
| Unternehmen | Position | Ende |
|---|---|---|
Kidney Care Partners
 Kidney Care Partners Medical/Nursing ServicesHealth Services Operates as nephrologists | Vorsitzender | 01.01.2024 |
| ZYNERBA PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 10.10.2023 |
| KERYX BIOPHARMACEUTICALS | Vorsitzender | 01.01.2017 |
| RELYPSA INC | Direktor/Vorstandsmitglied | 01.09.2016 |
American Kidney Fund, Inc.
 American Kidney Fund, Inc. Medical/Nursing ServicesHealth Services Provides treatment & financial assistance to kidney patients | Vorsitzender | 01.01.2015 |
Ausbildung von John Butler
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
82
Beziehungen ersten Grades
14
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 14 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Keryx Biopharmaceuticals, Inc.
 Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on therapies for patients with renal disease | Health Technology |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Zynerba Pharmaceuticals, Inc.
 Zynerba Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Delivers dermal solutions for the treatment of neuroscience disorders | Health Technology |
Inspiration Biopharmaceuticals, Inc.
 Inspiration Biopharmaceuticals, Inc. Medical SpecialtiesHealth Technology Produces intravenous recombinant therapies and develops non-invasive applications | Health Technology |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops pharmaceutical and diagnostic solutions | Health Technology |
Manhattan College
 Manhattan College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Baruch College
 Baruch College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Akebia Therapeutics, Inc.
 Akebia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for kidney diseases | Health Technology |
Kidney Care Partners
Kidney Care Partners Medical/Nursing ServicesHealth Services Operates as nephrologists | Health Services |
Relypsa, Inc.
 Relypsa, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops non-absorbed polymeric drugs for applications in cardiovascular and renal diseases | Health Technology |
American Kidney Fund, Inc.
American Kidney Fund, Inc. Medical/Nursing ServicesHealth Services Provides treatment & financial assistance to kidney patients | Health Services |
Wavebreak Therapeutics Ltd.
Wavebreak Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops small molecule therapeutics for multiple protein misfolding diseases | Health Technology |
Wählen Sie MarketScreener 
